140 related articles for article (PubMed ID: 1875580)
1. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
5. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Taga S; Ogawa K; Nakagawa T; Tano M
Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
[TBL] [Abstract][Full Text] [Related]
6. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
Shigeto E; Murakami I; Yokosaki Y
Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
[TBL] [Abstract][Full Text] [Related]
7. [A study on the intensive chemotherapy for previously untreated pulmonary tuberculosis--comparison of two regimens, SM-INH-RFP and SM-INH-EB (author's transl)].
Maekawa N; Kuze F; Inaba N; Ohi Y; Yamada E; Yasubuchi Y
Kekkaku; 1977 Jun; 52(6):299-306. PubMed ID: 904139
[No Abstract] [Full Text] [Related]
8. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
9. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Sato K; Ebe T
Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
[TBL] [Abstract][Full Text] [Related]
10. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
Mizutani S
Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
[TBL] [Abstract][Full Text] [Related]
13. [A clinical experience of DNA probe method for identifying Mycobacterium avium and Mycobacterium intracellulare].
Tsuda M; Oishi N; Saeki A; Ogawa K; Honda K; Sasamoto M; Michihiro H; Miwa T
Kekkaku; 1995 Jun; 70(6):369-76. PubMed ID: 7630072
[TBL] [Abstract][Full Text] [Related]
14. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
15. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
[TBL] [Abstract][Full Text] [Related]
17. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
[TBL] [Abstract][Full Text] [Related]
18. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
Oda T
Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
[No Abstract] [Full Text] [Related]
19. [A comparative study of pulmonary disease due to Mycobacterium avium and M. intracellulare identified by a newly developed DNA probe (Gen-Probe].
Mizutani S
Kekkaku; 1991 Jan; 66(1):19-38. PubMed ID: 2013966
[TBL] [Abstract][Full Text] [Related]
20. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
